Pfizer Pre-Tax Income 2010-2025 | PFE

Pfizer pre-tax income for the twelve months ending March 31, 2025 was $7.387B, a 512.45% decline year-over-year.

  • Pfizer annual pre-tax income for 2024 was $8.023B, a 658.32% increase from 2023.
  • Pfizer annual pre-tax income for 2023 was $1.058B, a 96.95% decline from 2022.
  • Pfizer annual pre-tax income for 2022 was $34.729B, a 42.85% increase from 2021.

Pfizer Pre-Tax Income 2010-2025 | PFE

  • Pfizer annual pre-tax income for 2024 was $8.023B, a 658.32% increase from 2023.
  • Pfizer annual pre-tax income for 2023 was $1.058B, a 96.95% decline from 2022.
  • Pfizer annual pre-tax income for 2022 was $34.729B, a 42.85% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B